Drug maker Alkem Laboratories Ltd and healthcare firms Narayana Hrudayalaya and Dr Lal Pathlabs are planning to launch their initial public offerings (IPOs) in the first half of December to collectively raise over Rs.2,500 crore ($377 million), according to several people aware of the development.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
